Expert Video - How will I know if my melanoma has responded to TIL therapy?

Rekha Chaudhary, MD, a medical hematologist and oncologist who specializes in the treatment of melanoma at the University of Cincinnati, explains that your doctor will monitor and perform regular scans to assess if your cancer is responding for the tumor infiltrating lymphocyte (TIL) therapy.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.

Please rate this content:

Other Modules:

 

This educational activity has been developed by the Melanoma Research Foundation (MRF), and Mechanisms in Medicine Inc.

This activity is supported by independent educational grants from Bristol-Myers Squibb, Foundation Medicine, Genentech, Iovance Biotherapeutics, Merck, Natera, and Novartis.

Bristol-Myers Squibb
Foundation Medicine
Genentech
Iovance
Merk
Natera
Novartis

This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.